Aksia-backed drug manufacturer COC Farmaceutici has acquired Tubilux Pharma, an Italian pharmaceutical company specialising in ophthalmology.
Buy-and-build specialist looks for portfolio add-ons as it contemplates hitting the road for a new fund in 2023
Three existing partners will lead the California office, which is the GP’s first beyond Europe
Executive led the US GP into other alternative assets like credit; no immediate successor announced
DACH industrial technology and IT investor has set a EUR 250m target for the vehicle